BioSpace News Archive

Press Releases

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting

September 29, 2025
·
5 min read
Press Releases

uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

September 29, 2025
·
4 min read
Press Releases

ImmuCell Announces Selection of its Next President and CEO

September 29, 2025
·
5 min read
Press Releases

Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14

September 29, 2025
·
1 min read
Press Releases

Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 29, 2025

September 29, 2025
·
2 min read
Press Releases

Accendatech’s Phase 3 Trial of ACT001, an Oral Compound with Novel MoA, Begins Enrolling Patients with Small Cell Lung Cancer with Brain Metastasis in a Highly Competitive Research Field

September 29, 2025
·
2 min read
Press Releases

Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by Ministry of Health, Labour and Welfare of Japan

September 29, 2025
·
5 min read
Press Releases

TAE Life Sciences Novel Boronated Drugs for BNCT in Combination with Immune Checkpoint Inhibitors Demonstrate Superior Tumor Growth Inhibition in Preclinical in vivo Models

September 29, 2025
·
2 min read
Press Releases

Spur® Elute DEEPER CORONARY Study Completes Enrollment

September 29, 2025
·
3 min read
Press Releases

Cell X Technologies and BioLamina enter a collaboration to advance standardization in iPSC-based therapeutics

September 29, 2025
·
3 min read